Dr. Markus Hosang is a General Partner and Managing Director at BioMed Partners. He has a strong pharmaceutical and VC background and joined BioMedPartners in 2004. Before he was Venture Partner at MPM Capital, managed their European office in Munich, and served on the board of several portfolio companies. Prior, at Roche, he held for nearly 20 years several senior management positions of increasing importance in the Global Pharma R&D organization. Among other responsibilities, he served on the Global Board of R&D Directors and the Pharma Portfolio Board. Most recently he was VP and CSO of Genetics and Integrated Medicine and a member of the Roche Genetics Executive Committee.
Dr. Hosang received his M.S. and Ph.D. degrees in Biochemistry from the ETH in Zurich, and pursued his postgraduate training at Stanford University Medical School and at the University of Washington in Seattle. He is Vice Chairman of the Board of Directors of Unitectra AG, the joint technology transfer office of the universities of Zurich, Basel and Bern.